Based in Japan and India. Has led to 1 successful fundraise in Japan. Been working the space of Venture Capital and Private Equity for the last 3 years.

Assurex Health, a personalized medicine company providing industry-leading treatment decision support to health care providers for behavioral and chronic pain conditions, today announced that it has secured $30 million in equity financing from new and existing investors, according to Virginia C. Drosos, Chairman and Chief Executive Officer

The funding will support increased clinical adoption and development of Assurex Health’s GeneSight products. GeneSight’s patented technology is based on combination pharmacogenomics (CPGxTM), a study of how variations in multiple genes influence individual drug reactions, informed by evidence-based medicine and clinical pharmacology.

‘We are pleased to welcome two new investors to this round of funding, the American Financial Group and Cross Creek Advisors,’ Drosos said. ‘We are also strongly supported by existing investors Cincinnati Children’s Hospital Medical Center, Sequoia Capital, Claremont Creek Ventures, Mayo Clinic, CincyTech, Allos Ventures and Danmar Capital. All investors have a proven track record, and we are thrilled to have them support our growth and expansion. They provide us with the means to move to the next stage of the company’s development and continue to chart our future course. ”

‘Through its proven value to patients and clinicians, Assurex Health has emerged as a market leader in pharmacogenomics,’ said Warren Hogarth, Partner, Sequoia Capital. ‘We are pleased to be part of this world-class company that has an impact on an increasing number of lives every day. Assurex Health offers a proven path to better outcomes for patients and families facing mental health and pain management challenges. This investment round will enable the company to reach more clinicians and patients while expanding its scientific and clinical foundations. ”

‘This technology has the potential to change how drugs are chosen for patients, including pediatric patients with neuropsychiatric disorders,’ said Michael Fisher, President and Chief Executive Officer of Cincinnati Children’s Hospital Medical Center. ‘We are proud to have been part of the company’s founding and to continue our support. ”

GeneSight Acceptance, Use Crowning
Over 9,000 clinicians have used GeneSight to help make treatment decisions for more than 125,000 patients across the country. In the last few months, the U Oh, S The Department of Veterans Affairs (VA) and Medicare, which provide medical coverage to more than 52 million Americans, have added GeneSight’s unique multi-gen psychotropic test to their coverage plans. The VA is America’s largest integrated health care system with more than 1,400 healthcare facilities serving nearly nine million veterans each year.

‘Our mission is to help health care providers improve patients’ treatment outcomes. Results from multiple clinical studies have shown that the combined approach of GeneSight results in better outcomes and lower costs for the healthcare system,” Drosos said. ‘Clinicians and patients share their personal success stories with us, and we want to bring those results to millions of people struggling with mental health issues themselves or with loved ones. ”

Approximately 61 Adults one in four According to the National Institutes of Health, 5 million Americans have experienced mental illness in a given year. One out of 17,’ about 13. 6 million people live with serious mental illness, such as major depression, schizophrenia or bipolar disorder. i It is also estimated that 490 million prescriptions are written annually for antidepressants and antipsychotics, with an economic consequence of $140 billion.

Assurex Health
Assurex Health is a personalized medicine company providing industry-leading decision-making support to clinicians for behavioral health conditions. Assurex Health’s proprietary GeneSight technology is based on combination pharmacogenomics (CPGxTM)-a study of genetic factors that influence individual drug response-as well as evidence-based medicine and clinical pharmacology. Assurex Health has licensed patented technology from Mayo Clinic and Cincinnati Children’s Hospital Medical Center, which remain technology contributors. Find out more at Insurexhealth Com

Leave a Reply

Your email address will not be published. Required fields are marked *